R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma

BACKGROUND: We investigated factors that influence outcomes in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab combined with the CHOP regimen (R-CHOP) followed by upfront autologous stem cell transplantation (Auto-SCT). METHODS: We retrospectively evaluated survival differences...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hong Ghi, Choi, Yunsuk, Kim, Sung-Yong, Kim, Inho, Kim, Yeo-Kyeoung, Kim, Yang Soo, Lee, Ho Sup, Kim, Seok Jin, Kim, Jeong-A, Park, Byeong-Bae, Park, Jinny, Shim, Hyeok, Eom, Hyeon Seok, Lee, Junglim, Park, Sung Kyu, Cheong, June-Won, Park, Keon Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090331/
https://www.ncbi.nlm.nih.gov/pubmed/25025012
http://dx.doi.org/10.5045/br.2014.49.2.107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090331/
https://www.ncbi.nlm.nih.gov/pubmed/25025012
http://dx.doi.org/10.5045/br.2014.49.2.107

Ejemplares similares